Examples of using Chronic phase in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Therefore, the starting dose of 100 mg once daily is the recommended initial dose for patients with chronic phase CML.
Chronic phase, newly diagnosed:
Posology for CML in adult patients The recommended dosage of Glivec is 400 mg/ day for patients in chronic phase CML.
In the study of chronic phase CML, 156(49%)
Mg twice daily in newly diagnosed patients with CML in the chronic phase.
or return to chronic phase RCP.
untreated CML in chronic phase have been enrolled in an open-label,
Transformed CML is the stage of the disease after its progression from chronic phase to accelerated phase(AP)
Based on these results, a positive benefit-risk of bosutinib in patients with previously untreated CML in the chronic phase has not been established.
no evidence of leukaemia or return to chronic phase.
Their occurrence is more frequent in patients with advanced phase CML or Ph+ ALL than in chronic phase CML.
Dasatinib was studied in a randomised clinical study of 519 patients with newly diagnosed CML in chronic phase which included patients with prior cardiac disease.
No cases of sudden death were reported in the Phase III study in newly diagnosed patients with CML in chronic phase.
Tasigna is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myelogenous leukaemia(CML) in the chronic phase.
The recommended dosage of Glivec is 400 mg/day for adult patients in chronic phase CML.
more frequent in patients with advanced phase CML or Ph+ ALL than in chronic phase CML see section 4.4.
For chronic phase CML, the starting dose of Sprycel is 100 mg once a day,
One randomized non-comparative trial was conducted in chronic phase patients who failed initial treatment with 400
In the study of chronic phase CML, the primary endpoint was MCyR in imatinib-resistant patients.
Clinical study in imatinib-resistant or intolerant CML in chronic phase, accelerated phase, and blast phase. .